Description

(25R)-3β-[[4-o-(4-o-β-D-Glucopyranosyl-β-D-Glucopyranosyl)-β-D-Galactopyranosyl]Oxy]-5α-Spirostan-12-One CAS NO 56316-35-9 is a high-purity steroidal saponin glycoside, a compound of significant interest in advanced pharmaceutical and biochemical research. Its complex molecular structure, featuring a spirostan core linked to a trisaccharide chain, makes it a valuable reference standard and a key intermediate for the synthesis of bioactive compounds. This product is essential for researchers and manufacturers in the pharmaceutical, nutraceutical, and life science sectors who require precise, high-quality chemical building blocks for drug discovery and development.

Application

• Pharmaceutical Reference Standard: Used for the qualitative and quantitative analysis of steroidal saponins in drug development and quality control laboratories.
• Biochemical Research: Serves as a critical intermediate or substrate in enzymatic studies and metabolic pathway investigations.
• Active Pharmaceutical Ingredient (API) Synthesis: Acts as a key precursor in the multi-step synthesis of novel therapeutic agents targeting various conditions.
• Natural Product Isolation & Standardization: Employed as a benchmark for the identification and standardization of plant extracts containing similar glycosidic compounds.
• Nutraceutical Development: Investigated for potential applications in the formulation of advanced dietary supplements.
• Academic Research: Utilized in university and institutional labs for studies in organic chemistry, pharmacology, and natural product chemistry.

Basic Information

Item	Details
Product Name	(25R)-3β-[[4-o-(4-o-β-D-Glucopyranosyl-β-D-Glucopyranosyl)-β-D-Galactopyranosyl]Oxy]-5α-Spirostan-12-One
CAS No.	56316-35-9
Molecular Formula	C45H72O19
Molecular Weight	917.05 g/mol
Synonyms	12-Oxotigogenin 3-O-β-D-glucopyranosyl-(1→4)-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside; (25R)-Spirostan-12-one, 3-[(O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-β-D-galactopyranosyl)oxy]-; Tigogenin-3-O-[β-D-glucopyranosyl-(1→4)-β-D-glucopyranosyl-(1→4)-β-D-galactopyranoside]-12-one; Steroidal Saponin Glycoside 56316-35-9; 12-Ketotigogenin triglycoside
EINECS	Contact for details

Quality Control

Our (25R)-3β-[[4-o-(4-o-β-D-Glucopyranosyl-β-D-Glucopyranosyl)-β-D-Galactopyranosyl]Oxy]-5α-Spirostan-12-One is produced and handled under a strict quality management system. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) detailing specific test results are available upon request to support your regulatory and quality assurance needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere conditions.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 95.0%
Loss on Drying	≤ 5.0%
Residue on Ignition	≤ 1.0%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.